Sean J Belouin
Overview
Explore the profile of Sean J Belouin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urrutia J, Anderson B, Belouin S, Berger A, Griffiths R, Grob C, et al.
J Psychoactive Drugs
. 2023 Sep;
55(5):523-538.
PMID: 37747281
As individuals and communities around the world confront mounting physical, psychological, and social threats, three complimentary mind-body-spirit pathways toward health, wellbeing, and human flourishing remain underappreciated within conventional practice among...
2.
Zia F, Baumann M, Belouin S, Dworkin R, Ghauri M, Hendricks P, et al.
Neuropharmacology
. 2023 Apr;
233:109528.
PMID: 37015315
Chronic pain is a leading cause of disability, reduced productivity, healthcare seeking behavior, and a contributor to opioid overdose in the United States. For many people, pain can be satisfactorily...
3.
Henningfield J, Coe M, Griffiths R, Belouin S, Berger A, Coker A, et al.
Neuropharmacology
. 2022 Aug;
218:109220.
PMID: 35987353
New medicines containing classic hallucinogenic and entactogenic psychedelic substance are under development for various psychiatric and neurological disorders. Many of these, including psilocybin, lysergic acid diethylamide (LSD), and 3,4-methylenedioxymethamphetamine (MDMA)...
4.
Belouin S, Averill L, Henningfield J, Xenakis S, Donato I, Grob C, et al.
Neuropharmacology
. 2022 Aug;
219:109214.
PMID: 35973601
There is mounting evidence suggesting psychedelic and entactogen medicines (namely psilocybin and 3,4-methylenedioxymethamphetamine [MDMA]), in conjunction with proper psychosocial support, hold the potential to provide safe, rapid acting, and robust...
5.
Belouin S, Henningfield J
Neuropharmacology
. 2018 Feb;
142:7-19.
PMID: 29476779
The purpose of this commentary is to provide an introduction to this special issue of Neuropharmacology with a historical perspective of psychedelic drug research, their use in psychiatric disorders, research-restricting...